GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » FCF Margin %

OrbusNeich Medical Group Holdings (FRA:Q8T) FCF Margin % : 0.98% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OrbusNeich Medical Group Holdings's Free Cash Flow for the six months ended in Dec. 2024 was €0.8 Mil. OrbusNeich Medical Group Holdings's Revenue for the six months ended in Dec. 2024 was €81.4 Mil. Therefore, OrbusNeich Medical Group Holdings's FCF Margin % for the quarter that ended in Dec. 2024 was 0.98%.

As of today, OrbusNeich Medical Group Holdings's current FCF Yield % is 0.48%.

The historical rank and industry rank for OrbusNeich Medical Group Holdings's FCF Margin % or its related term are showing as below:

FRA:Q8T' s FCF Margin % Range Over the Past 10 Years
Min: -1.54   Med: 10.09   Max: 15.76
Current: 1.12


During the past 6 years, the highest FCF Margin % of OrbusNeich Medical Group Holdings was 15.76%. The lowest was -1.54%. And the median was 10.09%.

FRA:Q8T's FCF Margin % is ranked better than
57.75% of 819 companies
in the Medical Devices & Instruments industry
Industry Median: -3.57 vs FRA:Q8T: 1.12


OrbusNeich Medical Group Holdings FCF Margin % Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings FCF Margin % Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
Get a 7-Day Free Trial 10.07 15.76 14.69 10.11 1.12

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.85 10.73 9.41 1.28 0.98

Competitive Comparison of OrbusNeich Medical Group Holdings's FCF Margin %

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrbusNeich Medical Group Holdings's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's FCF Margin % falls into.


;
;

OrbusNeich Medical Group Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

OrbusNeich Medical Group Holdings's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=1.76/156.713
=1.12 %

OrbusNeich Medical Group Holdings's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=0.795/81.354
=0.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrbusNeich Medical Group Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OrbusNeich Medical Group Holdings Business Description

Traded in Other Exchanges
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines